Abstract
Inflammatory Bowel Disease (IBD) shows increasing incidence in the world and are characterized as a relapsing chronic idiopathic inflammatory process of the gastrointestinal tract. Researching new drugs to treat IBD, which remains without cure, must be lead throughout interdisciplinary aspects, especially on the main mediators involved in the anti-inflammatory response of new potential su…